SARCOMA

One of the groups of malignant tumors that we investigated. After taking Procont, we got the following results:

– With sarcomas, the average survival time of the treated animals (280%) is significantly higher than in the control group (100%).

– The average tumor mass decreased by almost 2/3.

– The incidence of metastases significantly decreased when taking Procont in comparison with the positive control group. This is confirmed by histology, tumor markers with enzyme activity and laboratory diagnostic measurements.

Note:

* Control group – animals that were not given drugs

* SC – subcutaneous (injection)

* IP – intraperitoneal

* PO – per oral

News

ALL NEWS

2020.07.07

HOW TO PROTECT YOURSELF FROM CORONAVIRUS?

The most effective way (in addition to observing basic hygiene standards) is to strengthen the immune system. It is known...
MORE
2020.07.07

SARCOMA

One of the groups of malignant tumors that we investigated. After taking Procont, we got the following results: – With...
MORE
2020.07.07

SCIENTIFIC RESEARCH OF PROCONT

In 2000-2003, preclinical studies of the active substance of the product named Procont were conducted. They were held at the...
MORE
2020.07.06

MEDICAL CONFERENCE IN UKRAINE

In April of this year, we successfully held a conference in Hungary with the participation of experienced doctors from Ukraine....
MORE